BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15677477)

  • 1. Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors.
    Moucadel V; Constantinescu SN
    J Biol Chem; 2005 Apr; 280(14):13364-73. PubMed ID: 15677477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
    Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
    Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.
    Yamamura Y; Senda H; Noda M; Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():432-4. PubMed ID: 9209415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of the erythropoietin receptor or Stat5.
    Millot GA; Svinarchuk F; Lacout C; Vainchenker W; Dumenil D
    Br J Haematol; 2001 Feb; 112(2):449-58. PubMed ID: 11167846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.
    Santos SC; Lacronique V; Bouchaert I; Monni R; Bernard O; Gisselbrecht S; Gouilleux F
    Oncogene; 2001 Apr; 20(17):2080-90. PubMed ID: 11360192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines.
    Silva M; Benito A; Sanz C; Prosper F; Ekhterae D; Nuñez G; Fernandez-Luna JL
    J Biol Chem; 1999 Aug; 274(32):22165-9. PubMed ID: 10428780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
    Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
    J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification.
    Nelson EA; Walker SR; Alvarez JV; Frank DA
    J Biol Chem; 2004 Dec; 279(52):54724-30. PubMed ID: 15498775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation.
    Matsumoto A; Masuhara M; Mitsui K; Yokouchi M; Ohtsubo M; Misawa H; Miyajima A; Yoshimura A
    Blood; 1997 May; 89(9):3148-54. PubMed ID: 9129017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
    Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
    Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
    Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
    Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction.
    Socolovsky M; Fallon AE; Wang S; Brugnara C; Lodish HF
    Cell; 1999 Jul; 98(2):181-91. PubMed ID: 10428030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells.
    de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L
    Mol Cell Biol Res Commun; 2000 May; 3(5):299-305. PubMed ID: 10964754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway.
    Yoon D; Watowich SS
    Exp Hematol; 2003 Dec; 31(12):1310-6. PubMed ID: 14662339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
    Verdier F; Rabionet R; Gouilleux F; Beisenherz-Huss C; Varlet P; Muller O; Mayeux P; Lacombe C; Gisselbrecht S; Chretien S
    Mol Cell Biol; 1998 Oct; 18(10):5852-60. PubMed ID: 9742102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity.
    Gouilleux F; Pallard C; Dusanter-Fourt I; Wakao H; Haldosen LA; Norstedt G; Levy D; Groner B
    EMBO J; 1995 May; 14(9):2005-13. PubMed ID: 7744007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The G-CSF receptor carboxyl terminus, truncated in AML/SCN, is required for induction of a Stat5 protease activity.
    Qiu Y; Zhuang D; MacRae A; Dong F
    Leuk Res; 2005 Oct; 29(10):1153-62. PubMed ID: 16111533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
    Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
    Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.